VPIM
TNGX icon

Vanguard Personalized Indexing Management’s Tango Therapeutics TNGX Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$492K Buy
23,517
+3,115
+15% +$43.4K ﹤0.01% 1325
2025
Q4 		$181K Buy
20,402
+189
+0.9% +$1.63K ﹤0.01% 1739
2025
Q3 		$170K Sell
20,213
-156
-0.8% -$1.06K ﹤0.01% 1741
2025
Q2 		$104K Buy
20,369
+9,737
+92% +$24.1K ﹤0.01% 1729
2025
Q1 		$14.6K Buy
+10,632
New +$26.1K ﹤0.01% 1803

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Vanguard Personalized Indexing Management's TNGX Position: Q1 2026 in Review

Vanguard Personalized Indexing Management increased its Tango Therapeutics (TNGX) stake by 15% in Q1 2026, buying an estimated $43.4K and bringing the position to 23,517 shares worth $492K. The position accounts for ﹤0.01% of the portfolio, ranked #1325.

Vanguard Personalized Indexing Management first reported a position in TNGX in Q1 2025 and has held it in 5 quarters since. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • Vanguard Personalized Indexing Management held 23,517 shares of Tango Therapeutics worth $492K as of Q1 2026.
  • Vanguard Personalized Indexing Management bought 3,115 Tango Therapeutics shares in Q1 2026, an estimated $43.4K.
  • Tango Therapeutics made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q1 2026, its #1325 holding.
  • Vanguard Personalized Indexing Management first reported a position in Tango Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q1 2026, filed 14 May 2026.